{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:34:10Z","timestamp":1793068450563,"version":"4.5.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T00:00:00Z","timestamp":1716508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalradiologyonline.net","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.crad.2024.05.013","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T16:08:30Z","timestamp":1716566910000},"page":"639-656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prostate specific membrane antigen (PSMA) avid nonprostatic benign and malignant disease: a pictorial review"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5822-7553","authenticated-orcid":false,"given":"R.","family":"Srinivasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.J.R.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7412-5493","authenticated-orcid":false,"given":"N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5688-0153","authenticated-orcid":false,"given":"M.","family":"Subesinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2024.05.013_bib1","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.3390\/cancers14153638","article-title":"The role of PSMA PET\/CT in the primary diagnosis and follow-up of prostate cancer-A practical clinical review","volume":"14","author":"Lisney","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.crad.2024.05.013_bib2","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/pros.2990260308","article-title":"Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement","volume":"26","author":"Murphy","year":"1995","journal-title":"Prostate"},{"key":"10.1016\/j.crad.2024.05.013_bib3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1053\/j.sult.2020.04.004","article-title":"The role of PET-CT imaging in prostate cancer","volume":"41","author":"Subesinghe","year":"2020","journal-title":"Semin Ultrasound CT MR"},{"key":"10.1016\/j.crad.2024.05.013_bib4","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.eururo.2023.03.001","volume":"84","author":"Chow","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.crad.2024.05.013_bib5","article-title":"Head-to-Head comparison of (68)Ga-PSMA-11 PET\/CT and multiparametric MRI for pelvic lymph node staging prior to radical prostatectomy in patients with intermediate to high-risk prostate cancer: a meta-analysis","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.crad.2024.05.013_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jmir.2023.04.005","article-title":"The diagnostic accuracy of (68)Ga-PSMA PET\/CT versus (99m)Tc-MDP bone scintigraphy for identifying bone metastases in persons with prostate cancer: a systematic review","volume":"54","author":"Daniels","year":"2023","journal-title":"J Med Imaging Radiat Sci"},{"key":"10.1016\/j.crad.2024.05.013_bib7","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00256-019-03230-z","article-title":"Comparison of PSMA-PET\/CT, choline-PET\/CT, NaF-PET\/CT, MRI, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a systematic review and meta-analysis","volume":"48","author":"Zhou","year":"2019","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.crad.2024.05.013_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/RLU.0000000000002526","article-title":"Comparing the staging\/restaging performance of 68Ga-labeled prostate-specific membrane antigen and 18F-choline PET\/CT in prostate cancer: a systematic review and meta-analysis","volume":"44","author":"Lin","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib9","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1007\/s00330-022-08802-7","article-title":"Comparing the diagnostic performance of radiotracers in prostate cancer biochemical recurrence: a systematic review and meta-analysis","volume":"32","author":"Ma","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2024.05.013_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","volume":"77","author":"Perera","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.crad.2024.05.013_bib11","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41391-022-00544-3","article-title":"The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysis","volume":"26","author":"Pozdnyakov","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.crad.2024.05.013_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.eururo.2018.03.030","article-title":"Impact of (68)Ga-PSMA PET on the management of patients with prostate cancer: a systematic review and meta-analysis","volume":"74","author":"Han","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.crad.2024.05.013_bib13","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2214\/AJR.20.23912","article-title":"Diagnostic accuracy of (68)Ga-PSMA PET\/CT for initial detection in patients with suspected prostate cancer: a systematic review and meta-analysis","volume":"216","author":"Satapathy","year":"2021","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.crad.2024.05.013_bib14","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00259-021-05616-5","article-title":"Veit-Haibach P (68)Ga-PSMA PET in prostate cancer: a systematic review and meta-analysis of the observer agreement","volume":"49","author":"Chavoshi","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2024.05.013_bib15","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1177\/02841851231184210","article-title":"Diagnostic performance of 18F-labeled PSMA PET\/CT in patients with biochemical recurrence of prostate cancer: a systematic review and meta-analysis","volume":"64","author":"Yang","year":"2023","journal-title":"Acta Radiol"},{"key":"10.1016\/j.crad.2024.05.013_bib16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/RLU.0000000000004228","article-title":"The detection performance of 18 F-Prostate-Specific membrane antigen-1007 PET\/CT in primary prostate cancer : a systemic review and meta-analysis","volume":"47","author":"Huang","year":"2022","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib17","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3390\/tomography9040120","article-title":"Detection of biochemically recurrent prostate cancer with [(18)F]DCFPyL PET\/CT: an updated systematic review and meta-analysis with a focus on correlations with serum prostate-specific antigen parameters","volume":"9","author":"Sadaghiani","year":"2023","journal-title":"Tomography"},{"key":"10.1016\/j.crad.2024.05.013_bib18","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.eururo.2023.06.018","article-title":"Diagnostic performance and safety of positron emission tomography with (18)F-rhPSMA-7.3 in patients with newly diagnosed unfavourable intermediate- to very-high-risk prostate cancer: results from a phase 3, prospective, multicentre study (LIGHTHOUSE)","volume":"84","author":"Surasi","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.crad.2024.05.013_bib19","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/JU.0000000000003598","article-title":"Diagnostic performance and safety of (18)F-rhPSMA-7.3 positron emission tomography in men with suspected prostate cancer recurrence: results from a phase 3, prospective, multicenter study (SPOTLIGHT). Reply","volume":"210","author":"Jani","year":"2023","journal-title":"J Urol"},{"key":"10.1016\/j.crad.2024.05.013_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40644-020-00300-7","article-title":"Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings","volume":"20","author":"de Galiza Barbosa","year":"2020","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.crad.2024.05.013_bib21","first-page":"927","article-title":"Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients","volume":"7","author":"Horoszewicz","year":"1987","journal-title":"Anticancer Res"},{"key":"10.1016\/j.crad.2024.05.013_bib22","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1073\/pnas.93.2.749","article-title":"Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase","volume":"93","author":"Carter","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.crad.2024.05.013_bib23","first-page":"1445","article-title":"Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells","volume":"2","author":"Pinto","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.crad.2024.05.013_bib24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.23736\/S1824-4785.17.02977-6","article-title":"Radiolabeled prostate-specific membrane antigen small-molecule inhibitors","volume":"61","author":"Will","year":"2017","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2024.05.013_bib25","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2967\/jnumed.117.203877","article-title":"Perspective on the evolving story of PSMA biology, PSMA-based imaging, and endoradiotherapeutic strategies","volume":"59","author":"O'Keefe","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1200\/EDBK_239187","article-title":"The evolving role of prostate-specific membrane antigen-based diagnostics and therapeutics in prostate cancer","volume":"39","author":"Dorff","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.crad.2024.05.013_bib27","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3390\/cancers12061367","article-title":"PSMA theranostics: review of the current status of PSMA-targeted imaging and radioligand therapy","volume":"12","author":"Jones","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.crad.2024.05.013_bib28","first-page":"919","article-title":"PSMA expression on neovasculature of solid tumors","volume":"35","author":"Van de Wiele","year":"2020","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.crad.2024.05.013_bib29","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2967\/jnumed.117.203570","article-title":"Imaging of nonprostate cancers using PSMA-targeted radiotracers: rationale, current state of the field, and a call to arms","volume":"59","author":"Salas Fragomeni","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1159\/000447688","article-title":"Prostate-Specific membrane antigen PET\/CT: false-positive results due to sarcoidosis?","volume":"9","author":"Hermann","year":"2016","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.crad.2024.05.013_bib31","doi-asserted-by":"crossref","first-page":"e433","DOI":"10.1097\/RLU.0000000000001769","article-title":"Prostate-Specific membrane antigen-targeted imaging with [18F]DCFPyL in high-grade gliomas","volume":"42","author":"Salas Fragomeni","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00259-015-3235-y","article-title":"Intense PSMA-expression using (68)Ga-PSMA PET\/CT in a paravertebral schwannoma mimicking prostate cancer metastasis","volume":"43","author":"Rischpler","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2024.05.013_bib33","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2967\/jnumed.117.190215","article-title":"Detection of synchronous primary malignancies with (68)Ga-labeled prostate-specific membrane antigen PET\/CT in patients with prostate cancer: frequency in 764 patients","volume":"58","author":"Osman","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib34","doi-asserted-by":"crossref","first-page":"e637","DOI":"10.1097\/RLU.0000000000004236","article-title":"Intense 68 Ga-PSMA uptake in neurofibroma mimicking cutaneous metastases in a patient with prostate cancer","volume":"47","author":"Erol Fenercioglu","year":"2022","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib35","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1097\/RLU.0000000000001569","article-title":"Incidental detection of head and neck squamous cell carcinoma on 68Ga-PSMA-11 PET\/CT","volume":"42","author":"Lawhn-Heath","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib36","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.3390\/cancers14153585","article-title":"PSMA PET imaging and therapy in adenoid cystic carcinoma and other salivary gland cancers: a systematic review","volume":"14","author":"Tan","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.crad.2024.05.013_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/RLU.0000000000001935","article-title":"Nielsen GL 68Ga-PSMA avid primary adenocarcinoma of the lung with complementary low 18F-FDG uptake","volume":"43","author":"Jochumsen","year":"2018","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib38","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/RLU.0000000000003270","article-title":"68Ga-PSMA-Avid small cell lung cancer on PET\/CT: incidental second malignancy in treated prostate cancer","volume":"45","author":"Sharma","year":"2020","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib39","doi-asserted-by":"crossref","first-page":"E406","DOI":"10.1111\/ans.14694","article-title":"Prostate-specific membrane antigen avidity on positron emission tomography scan in malignant pleural mesothelioma","volume":"89","author":"Ekanayake","year":"2019","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.crad.2024.05.013_bib40","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/RLU.0000000000004408","article-title":"Intense diffuse lung uptake due to interstitial pneumopathy related to polyangiitis granulomata in 68 Ga-PSMA-11 PET\/CT","volume":"48","author":"Moreau","year":"2023","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/RLU.0000000000001543","article-title":"PSMA uptake in mediastinal sarcoidosis","volume":"42","author":"Ardies","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib42","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1097\/RLU.0000000000001782","article-title":"68Ga-PSMA-Ligand PET\/CT uptake in anthracosilicosis","volume":"42","author":"McGuiness","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib43","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1097\/RLU.0000000000002563","article-title":"68Ga-Prostate-Specific membrane antigen PET\/CT in cholangiocarcinoma: a potential biomarker for targeted radioligand therapy?","volume":"44","author":"Marafi","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/RLU.0000000000002103","article-title":"68Ga-Labeled PSMA uptake in nonprostatic malignancies: has the time come to remove \"PS\" from PSMA?","volume":"43","author":"Malik","year":"2018","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib45","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1097\/RLU.0000000000002347","article-title":"Gastric GIST incidentally detected on 68Ga-PSMA-PET\/CT: correlation between functional imaging and histology","volume":"43","author":"Vaz","year":"2018","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib46","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.2967\/jnumed.120.257915","article-title":"(68)Ga-PSMA-11 PET\/CT improves tumor detection and impacts management in patients with hepatocellular carcinoma","volume":"62","author":"Hirmas","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib47","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s00330-020-07318-2","article-title":"Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET\/CT as a new diagnostic avenue","volume":"31","author":"Krishnaraju","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2024.05.013_bib48","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.3390\/jcm11071829","article-title":"PSMA PET\/CT in renal cell carcinoma: an overview of current literature","volume":"11","author":"Muselaers","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.crad.2024.05.013_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12149-017-1216-x","article-title":"Low levels of PSMA expression limit the utility of (18)F-DCFPyL PET\/CT for imaging urothelial carcinoma","volume":"32","author":"Campbell","year":"2018","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib50","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1007\/s00261-023-03957-3","article-title":"Distribution of prostate specific membrane antigen (PSMA) on PET-MRI in patients with and without ovarian cancer","volume":"48","author":"Sadowski","year":"2023","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.crad.2024.05.013_bib51","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1097\/RLU.0000000000001384","article-title":"Prostate-Specific membrane antigen PET\/CT findings for hepatic hemangioma","volume":"41","author":"Bhardwaj","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib52","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/RLU.0000000000002662","article-title":"Incidental detection of splenic hemangioma on 68Ga-PSMA PET\/CT","volume":"44","author":"Sheng","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib53","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/RLU.0000000000001423","article-title":"Serous cystadenoma of the pancreas showing uptake on 68Ga PSMA PET\/CT","volume":"42","author":"Chan","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib54","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/RLU.0000000000002064","article-title":"Prostate-Specific membrane antigen expression in adrenocortical carcinoma on 68Ga-Prostate-Specific membrane antigen PET\/CT","volume":"43","author":"Arora","year":"2018","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib55","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/RLU.0000000000002997","article-title":"68Ga-Prostate-Specific membrane antigen uptake in a pancreatic neuroendocrine tumor","volume":"45","author":"Luong","year":"2020","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib56","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13550-020-00720-3","article-title":"Gallium-68 prostate-specific membrane antigen ([(68)Ga]Ga-PSMA-11) PET for imaging of thyroid cancer: a feasibility study","volume":"10","author":"Lawhn-Heath","year":"2020","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.crad.2024.05.013_bib57","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/1754-9485.12357","article-title":"Gallium-68 PSMA uptake in adrenal adenoma","volume":"60","author":"Law","year":"2016","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.crad.2024.05.013_bib58","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/RLU.0000000000001084","article-title":"Follicular thyroid adenoma showing avid uptake on 68Ga PSMA-HBED-CC PET\/CT","volume":"41","author":"Kanthan","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib59","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/RLU.0000000000004896","article-title":"Incidental detection of parathyroid adenoma on 18F-PSMA PET\/CT","volume":"48","author":"Broos","year":"2023","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib60","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1097\/RLU.0000000000002581","article-title":"Vivo PSMA expression in head and neck paragangliomas on 68Ga PSMA 11 PET\/CT","volume":"44","author":"Tripathy","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib61","first-page":"32","article-title":"Radiolabelled PSMA PET\/CT in breast cancer. A systematic review","volume":"23","author":"Bertagna","year":"2020","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"10.1016\/j.crad.2024.05.013_bib62","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/RLU.0000000000001445","article-title":"68Ga-PSMA expression in pseudoangiomatous stromal hyperplasia of the breast","volume":"42","author":"Malik","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib63","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1097\/MNM.0000000000001465","article-title":"Head-to-head comparison between 68Ga-PSMA and 18F-FDG-PET\/CT in lymphomas: a preliminary analysis","volume":"42","author":"de Souza","year":"2021","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.crad.2024.05.013_bib64","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1097\/RLU.0000000000001479","article-title":"68Ga-PSMA PET\/CT imaging in multiple myeloma","volume":"42","author":"Sasikumar","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib65","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/RLU.0000000000002964","article-title":"Alan selcuk N myelodysplastic syndrome presenting with diffuse bone marrow uptake on 68Ga-PSMA PET\/CT","volume":"45","author":"Arslan","year":"2020","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib66","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20220886","article-title":"De Geus-Oei L Prostate-specific membrane antigen (PSMA) as a potential target for molecular imaging and treatment in bone and soft tissue sarcomas","volume":"96","author":"Kleiburg","year":"2023","journal-title":"Br J Radiol"},{"key":"10.1016\/j.crad.2024.05.013_bib67","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/RLU.0000000000002111","article-title":"Incidental metastatic Melanoma identified on 68Ga-Prostate-Specific membrane antigen PET\/CT for metastatic prostate cancer","volume":"43","author":"Snow","year":"2018","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib68","doi-asserted-by":"crossref","first-page":"991","DOI":"10.21037\/tau-20-1099","article-title":"18)F-PSMA-1007 PET\/CT uptake in multiple angiolipomas caused by PSMA expression in capillaries: a case report","volume":"10","author":"Wang","year":"2021","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.crad.2024.05.013_bib69","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1097\/RLU.0000000000002387","article-title":"Juvenile nasal angiofibroma on 68Ga-PSMA PET\/CT: opening new frontiers","volume":"44","author":"Sakthivel","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib70","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/RLU.0000000000001650","article-title":"Uptake of an acrochordon incidentally detected on 68Ga prostate-specific membrane antigen PET\/CT","volume":"42","author":"Daglioz","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib71","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/RLU.0000000000004649","article-title":"PSMA PET\/CT detection of chondromyxoid fibroma","volume":"48","author":"Jang","year":"2023","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib72","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/RLU.0000000000001591","article-title":"68Ga-PSMA uptake by dermatofibroma in a patient with prostate cancer","volume":"42","author":"Aydin","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib73","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/RLU.0000000000001192","article-title":"Desmoid tumor showing intense uptake on 68Ga PSMA-HBED-CC PET\/CT","volume":"41","author":"Kanthan","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib74","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/MNM.0000000000000716","article-title":"Uptake of the prostate-specific membrane antigen-targeted PET radiotracer 18F-DCFPyL in elastofibroma dorsi","volume":"38","author":"Gorin","year":"2017","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.crad.2024.05.013_bib75","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/RLU.0000000000001631","article-title":"Vertebral hemangioma mimicking bone metastasis in 68Ga-PSMA ligand PET\/CT","volume":"42","author":"Artigas","year":"2017","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib76","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1097\/RLU.0000000000004769","article-title":"68 Ga-Prostate-Specific membrane antigen PET\/CT in imaging of hemangiopericytoma","volume":"48","author":"Kunikowska","year":"2023","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib77","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/RLU.0000000000001296","article-title":"Paget disease: a potential pitfall in PSMA PET for prostate cancer","volume":"41","author":"Blazak","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib78","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1097\/RLU.0000000000002546","article-title":"68Ga-PSMA uptake in fibrous dysplasia","volume":"44","author":"Reale","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib79","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients","volume":"31","author":"Bubendorf","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.crad.2024.05.013_bib80","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2214\/AJR.21.27323","article-title":"Head-to-Head comparison of (68)Ga-PSMA-11 PET\/CT and (99m)Tc-mdp bone scintigraphy for the detection of bone metastases in patients with prostate cancer: a meta-analysis","volume":"219","author":"Zhao","year":"2022","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.crad.2024.05.013_bib81","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1148\/rg.2019180079","article-title":"Revisiting prostate cancer recurrence with PSMA PET: atlas of typical and atypical patterns of spread","volume":"39","author":"Barbosa","year":"2019","journal-title":"Radiographics"},{"key":"10.1016\/j.crad.2024.05.013_bib82","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2967\/jnumed.119.241174","article-title":"Factors predicting metastatic disease in (68)Ga-PSMA-11 PET-positive osseous lesions in prostate cancer","volume":"61","author":"Chiu","year":"2020","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib83","doi-asserted-by":"crossref","first-page":"e529","DOI":"10.1097\/RLU.0000000000004259","article-title":"Bone uptake in prostate cancer patients: diagnostic performances of PSMA-RADS v1.0, clinical, biological, and 68 Ga-PSMA-11 PET features to predict metastasis after biochemical recurrence","volume":"47","author":"Letang","year":"2022","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib84","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00259-021-05245-y","article-title":"E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET","volume":"48","author":"Ceci","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2024.05.013_bib85","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2214\/AJR.10.7222","article-title":"Imaging of Paget disease of bone and its musculoskeletal complications: review","volume":"196","author":"Theodorou","year":"2011","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.crad.2024.05.013_bib86","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/bju.15152","article-title":"Solitary rib lesions showing prostate-specific membrane antigen (PSMA) uptake in pre-treatment staging (68) Ga-PSMA-11 positron emission tomography scans for men with prostate cancer: benign or malignant?","volume":"126","author":"Chen","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.crad.2024.05.013_bib87","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2967\/jnumed.122.264334","article-title":"Predicting outcomes of indeterminate bone lesions on (18)F-DCFPyL PSMA PET\/CT scans in the setting of high-risk primary or recurrent prostate cancer","volume":"64","author":"Phelps","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib88","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1007\/s00259-021-05424-x","article-title":"Focal unspecific bone uptake on [(18)F]-PSMA-1007 PET: a multicenter retrospective evaluation of the distribution, frequency, and quantitative parameters of a potential pitfall in prostate cancer imaging","volume":"48","author":"Grunig","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2024.05.013_bib89","doi-asserted-by":"crossref","first-page":"738","DOI":"10.2967\/jnumed.118.215434","article-title":"Unspecific (18)F-PSMA-1007 bone uptake evaluated through PSMA-11 PET, bone scanning, and MRI triple validation in patients with biochemical recurrence of prostate cancer","volume":"64","author":"Seifert","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib90","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1007\/s00259-023-06214-3","article-title":"Head-to-head comparison of [(68)Ga]Ga-PSMA-11 and [(18)F]FDG PET\/CT in multiple myeloma","volume":"50","author":"Souza","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2024.05.013_bib91","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11899-019-00499-8","article-title":"Solitary plasmacytoma: a review of diagnosis and management","volume":"14","author":"Pham","year":"2019","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.crad.2024.05.013_bib92","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.semnuclmed.2023.11.001","article-title":"A practical guide to the pearls and pitfalls of PSMA PET imaging","volume":"54","author":"Voter","year":"2024","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib93","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s40644-018-0154-8","article-title":"(68) Ga-PSMA-PET\/CT for the evaluation of pulmonary metastases and opacities in patients with prostate cancer","volume":"18","author":"Damjanovic","year":"2018","journal-title":"Cancer Imaging"},{"key":"10.1016\/j.crad.2024.05.013_bib94","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2967\/jnumed.115.164442","article-title":"68Ga-PSMA-HBED-CC PET for differential diagnosis of suggestive lung lesions in patients with prostate cancer","volume":"57","author":"Pyka","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib95","article-title":"Endobronchial metastases 20 years after prostate cancer excision","volume":"27","author":"Hatakeyama","year":"2019","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.crad.2024.05.013_bib96","article-title":"Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer","volume":"12","author":"Schmidt","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.crad.2024.05.013_bib97","article-title":"Expression of prostate-specific membrane antigen in lung cancer cells and tumor neovasculature endothelial cells and its clinical significance","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.crad.2024.05.013_bib98","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00259-016-3573-4","article-title":"F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients","volume":"44","author":"Giesel","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2024.05.013_bib99","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2967\/jnumed.118.214833","article-title":"(68)Ga-PSMA is a novel PET-CT tracer for imaging of hepatocellular carcinoma: a prospective pilot study","volume":"60","author":"Kesler","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/tomography9010011","article-title":"Comparison between PSMA PET\/CT and MRI for characterizing hepatocellular carcinoma: a real-world study","volume":"9","author":"Wong","year":"2023","journal-title":"Tomography"},{"key":"10.1016\/j.crad.2024.05.013_bib101","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep4.1861","article-title":"PSMA as a theranostic target in hepatocellular carcinoma: immunohistochemistry and (68) Ga-PSMA-11 PET using cyclotron-produced (68) Ga","volume":"6","author":"Thompson","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.crad.2024.05.013_bib102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14309\/ctg.0000000000000041","article-title":"Expression of prostate-specific membrane antigen in tumor-associated vasculature predicts poor prognosis in hepatocellular carcinoma","volume":"10","author":"Jiao","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.crad.2024.05.013_bib103","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.18632\/oncotarget.27024","article-title":"Prostate-specific membrane antigen expression in hepatocellular carcinoma: potential use for prognosis and diagnostic imaging","volume":"10","author":"Tolkach","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.crad.2024.05.013_bib104","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2967\/jnumed.120.245605","article-title":"(68)Ga-PSMA PET\/CT for primary lymph node and distant metastasis NM staging of high-risk prostate cancer","volume":"62","author":"Klingenberg","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.semnuclmed.2023.06.005","article-title":"Hofman MS role of FDG PET\/CT in management of patients with prostate cancer","volume":"54","author":"Sutherland","year":"2024","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.crad.2024.05.013_bib106","article-title":"Prostate cancer with metastases to the kidney: a rare manifestation of a common disease","volume":"2013","author":"Khan","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.crad.2024.05.013_bib107","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12894-017-0227-1","article-title":"A rare presentation of metastatic prostate cancer, initially a suspect for urothelial cell carcinoma of the ureter: a case report","volume":"17","author":"Chung","year":"2017","journal-title":"BMC Urol"},{"key":"10.1016\/j.crad.2024.05.013_bib108","doi-asserted-by":"crossref","DOI":"10.1093\/jscr\/rjac275","article-title":"Prostate cancer metastasis mimicking a primary urothelial carcinoma of the bladder","volume":"2022","author":"Spazzapan","year":"2022","journal-title":"J Surg Case Rep"},{"key":"10.1016\/j.crad.2024.05.013_bib109","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4103\/iju.IJU_175_18","article-title":"Urethral metastasis with neuroendocrine differentiation in a patient with prostate cancer treated with hormone deprivation","volume":"35","author":"Sabharwal","year":"2019","journal-title":"Indian J Urol"},{"key":"10.1016\/j.crad.2024.05.013_bib110","first-page":"4049","article-title":"Expression of prostate-specific membrane antigen in transitional cell carcinoma of the bladder: prognostic value?","volume":"6","author":"Gala","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.crad.2024.05.013_bib111","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/j.humpath.2009.06.003","article-title":"Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers","volume":"40","author":"Haffner","year":"2009","journal-title":"Hum Pathol"},{"key":"10.1016\/j.crad.2024.05.013_bib112","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s12032-014-0857-z","article-title":"Prostate-specific membrane antigen as a marker of pancreatic cancer cells","volume":"31","author":"Ren","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.crad.2024.05.013_bib113","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.3390\/curroncol30040295","article-title":"Prostate cancer metastasis to stomach: a case report and review of literature","volume":"30","author":"Moshref","year":"2023","journal-title":"Curr Oncol"},{"key":"10.1016\/j.crad.2024.05.013_bib114","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/826273","article-title":"Pancreatic metastasis from prostate cancer","volume":"2010","author":"Jacob","year":"2010","journal-title":"Case Rep Med"},{"key":"10.1016\/j.crad.2024.05.013_bib115","article-title":"Potential role of PSMA-targeted PET in thyroid malignant disease: a systematic review","volume":"13","author":"Rizzo","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.crad.2024.05.013_bib116","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13550-019-0559-9","article-title":"PSMA expression level predicts differentiated thyroid cancer aggressiveness and patient outcome","volume":"9","author":"Sollini","year":"2019","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.crad.2024.05.013_bib117","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13550-020-0610-x","article-title":"(68)Ga-PSMA PET\/CT in radioactive iodine-refractory differentiated thyroid cancer and first treatment results with (177)Lu-PSMA-617","volume":"10","author":"de Vries","year":"2020","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.crad.2024.05.013_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13225688","article-title":"Prostate-Specific membrane antigen in anaplastic and poorly differentiated thyroid cancer-A new diagnostic and therapeutic target?","volume":"13","author":"Wachter","year":"2021","journal-title":"Cancers (Basel)"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926024002551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926024002551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T03:40:13Z","timestamp":1723002013000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926024002551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":118,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0009926024002551"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2024.05.013","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate specific membrane antigen (PSMA) avid nonprostatic benign and malignant disease: a pictorial review","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2024.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}]}}